FOS expression in blood as a LDL-independent marker of statin treatment.
about
NaviSE: superenhancer navigator integrating epigenomics signal algebra.Gene expression profiling of peripheral blood mononuclear cells in the setting of peripheral arterial disease.NF-κB pathway is involved in CRP-induced effects on pulmonary arterial endothelial cells in chronic thromboembolic pulmonary hypertension.Differentially expressed genes in human peripheral blood as potential markers for statin response
P2860
FOS expression in blood as a LDL-independent marker of statin treatment.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
FOS expression in blood as a LDL-independent marker of statin treatment.
@ast
FOS expression in blood as a LDL-independent marker of statin treatment.
@en
FOS expression in blood as a LDL-independent marker of statin treatment.
@nl
type
label
FOS expression in blood as a LDL-independent marker of statin treatment.
@ast
FOS expression in blood as a LDL-independent marker of statin treatment.
@en
FOS expression in blood as a LDL-independent marker of statin treatment.
@nl
prefLabel
FOS expression in blood as a LDL-independent marker of statin treatment.
@ast
FOS expression in blood as a LDL-independent marker of statin treatment.
@en
FOS expression in blood as a LDL-independent marker of statin treatment.
@nl
P2093
P2860
P1433
P1476
FOS expression in blood as a LDL-independent marker of statin treatment.
@en
P2093
Arshed A Quyyumi
Cynthia L Brenneman
Flavia M Facio
Ho Joong Sung
Ju-Gyeong Kang
Paul M Hwang
Salman Sher
Sarah I Jawed
Vandana Sachdev
Yesoda N Rao
P2860
P304
P356
10.1016/J.ATHEROSCLEROSIS.2010.06.023
P577
2010-06-19T00:00:00Z